796875-53-1 Usage
Uses
Used in Cosmetic Industry:
4-(t-Butyl)-2-Ethoxy Benzoic Acid is used as a sunscreen agent for its capacity to absorb UVB radiation, thereby protecting the skin from sunburn and other harmful effects of UV rays. It is a key ingredient in sunscreens and other skincare products, where it acts by absorbing and reflecting the UV radiation.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 4-(t-Butyl)-2-Ethoxy Benzoic Acid is utilized for various medicinal applications, although the specific uses are not detailed in the provided materials. Its inclusion in this industry suggests that it may have properties that contribute to the development or effectiveness of certain medications.
Check Digit Verification of cas no
The CAS Registry Mumber 796875-53-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,6,8,7 and 5 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 796875-53:
(8*7)+(7*9)+(6*6)+(5*8)+(4*7)+(3*5)+(2*5)+(1*3)=251
251 % 10 = 1
So 796875-53-1 is a valid CAS Registry Number.
InChI:InChI=1/C13H18O3/c1-5-16-11-8-9(13(2,3)4)6-7-10(11)12(14)15/h6-8H,5H2,1-4H3,(H,14,15)
796875-53-1Relevant academic research and scientific papers
Small Molecules Simultaneously Inhibiting p53-Murine Double Minute 2 (MDM2) Interaction and Histone Deacetylases (HDACs): Discovery of Novel Multitargeting Antitumor Agents
He, Shipeng,Dong, Guoqiang,Wu, Shanchao,Fang, Kun,Miao, Zhenyuan,Wang, Wei,Sheng, Chunquan
, p. 7245 - 7260 (2018/08/03)
p53-Murine double minute 2 (MDM2) interaction and histone deacetylases (HDACs) are important targets in antitumor drug development. Inspired by the synergistic effects between MDM2 and HDACs, the first MDM2/HDACs dual inhibitors were identified, which sho
A practical synthesis of a cis -4,5-Bis(4-chlorophenyl)imidazoline Intermediate for Nutlin analogues
Shu, Lianhe,Wang, Ping,Liu, Wen,Gu, Chen
, p. 1866 - 1869 (2013/01/15)
A practical synthesis of cis-4,5-bis(4-chlorophenyl)imidazoline, a key intermediate for Nutlin analogues, is reported. The title compound was prepared in 81-88% yield by boric acid catalyzed direct condensation of meso-bis(4-chlorophenyl)ethane-1,2-diamine with a benzoic acid. The process was successfully scaled up in a pilot plant, resulting in >15 kg of the product.
